Table 1.

(A) Nanomedicines; (B) Propelling systems applied to nanodevices; (C) Biomolecules as nanostructures in therapeutics.

(A) NANOMEDICINES AVAILABLE IN THE MARKET AND THEIR INDICATIONS
Drug	Nano carrier	Application	Brand name
Paclitaxel	Albumin-bound nanoparticles	Metastatic breast cancer	Abraxane®
Doxorubicin	Liposomes	Metastatic breast cancer	Myocet®
Doxorubicin	PEGylated liposomes	Metastatic breast and ovarian cancer; Kaposi sarcoma	Caelyx®
Daunorubicin	Liposome	Kaposi sarcoma	DaunoXome®
Amphotericin B	Liposome	Fungal infections and cutaneous leishmaniasis	AmBisome®
Monoclonal sheep antibody	PAMAM dendrimers	Cardiac marker diagnostic	Stratus®
(B) PROPELLING SYSTEMS
Propulsion mode	Nano carrier	Application
Catalytic	Multilayer microtubes (5)	Immuno-micromachine-based approach for in vitro detection circulating tumor cells without sample preprocessing (6)
Magnetic	Tumbling nanowires (7)	Magnetic resonance guided microcarrier for liver chemoembilization (8)
Ultrasound	Mutilayer microtubes (9)	Acoustically active microbubbles for effective therapies in primary central nervous system lymphoma (10)
(C) BIOMOLECULES AS NANOSTRUCTURES IN THERAPEUTICS
Biomolecule	Application
Proteins	Self assembly nanopeptide vaccines to display B-cell epitope from the malaria parasite Plasmodium berghei circumsporozoite protein (20)
RNA	Transferrin-tagged, cyclodextrin-based polymeric nanoparticles-CALAA-01, contains siRNA that targets the M2 subunit of ribonucleotide reductase for cancer treatment (21)
	HIVgp120: tat-rev siRNA chimera, a 16-nt dsRNA used as the scaffold to link the gp120 aptamer; decreases infection by blocking gp120 and prevents replication by silencing tat-rev (22)
DNA	Cancer-fighting DNA nanorobots that target specific cells for repair (23)